Roche Holding Ltd. (RO) and Amylin Pharmaceuticals Inc. (AMLN) A diabetes drug produced by Roche has experienced a setback after the firm said adverse reactions to the drug – Taspoglutide – have forced the company to make changes to ongoing clinical trials, creating concern over both the drug’s timeline to approval and its ability to compete successfully [...]